Upcoming Pump.Science Launch, Can the New Compound Project Compare to Rif/Uro?

Original Title: "New Launch on Pump.Science Platform, Can the New Compound Project Rival Rif/Uro?"
Source: Biteye

Previously with Pump.fun's million-dollar daily pumps, and currently with CZ's shills on Four.Meme, the on-chain launch platform's casino effect is still hot. On February 8, the long-silent DeSci (Decentralized Science) track also welcomed the news of the longstanding project Pump.Science's upcoming launch of a new launch platform next week. As soon as the news came out, $Rif and $Uro both surged by 20%. Previously, Pump.Science co-founder Benjels had stated in an interview that they would launch 20 new compound tokens by Christmas 2024.

However, in reality, he postponed this action until now. Over the past three months, with external factors such as rate cuts affecting them, Pump.Science's official tokens $Rif and $Uro have dropped more than 95% from their market cap highs of 240m and 140m, respectively, while during the same period, the DeSci financial layer project BIO, after being listed on Binance, has also fallen by around 90% from its market cap high. The DeSci track, hyped by endorsements from CZ, Vitalik, and other big names, can be said to be in a sorry state. It seems that this highly anticipated new narrative that could further drive mass adoption has become a target of universal criticism.

Will the New Launch Platform Trigger a Renaissance of DeSci?

According to official documentation from the Pump.Science community, the process of the new launch platform is as follows:

① Users will list a compound together with a token on the Pump.Science platform.

② Users can buy and sell tokens on the same Bonding Curve as Pump.fun to support the research of this compound. 79% of the tokens are issued along the Bonding Curve. When the token market cap reaches 303 Sol (of which 85 Sol is in circulation), the Bonding Curve will close. 82 Sol of liquidity will move to Meteora for trading. 3 Sol will be used to pay for the corresponding worm experiments.

Of particular note, the Pump.Science new launch platform will implement a dynamic fee structure to prevent sniper bots and prevent front-running during the initial token sale. Specific measures include:

① Bot Deterrence: The dynamic fee structure is specifically designed to reduce front-running by sniper bots.
② Early Risk: The fees for the first 150 slots (about 2 minutes) are extremely high (99.99%), which will significantly reduce the amount of tokens buyers receive.
③ Monitoring Activity: Between slots 150-250 (2-4 mins), the fees will rapidly decrease.

Dynamic Fee Structure Curve:

The whitepaper also states that all new compounds must airdrop a certain share to the builders and holders of $Rif and $Uro. Undoubtedly, Pump.Science's launch of a new token issuance platform is a grandiose "self-rescue" effort. The weak DeSci track is in urgent need of new attention hotspots and the emergence of wealth effects. Nowadays, hunters on the Solana chain have been lost in a variety of AI Agents and celebrity coins for too long, exhausted both physically and mentally, while the BSC chain sees CZ making clear calls for separate ways. In the crisis-ridden chain, can the DeSci frenzy be reignited like Rif and Uro to turn the tide? With new compounds, a new Dev, and the addition of new attention increments, can more DeSci gameplay be activated to attract fresh liquidity? Three months after the grand announcement of the DeSci project, it has indeed come to a critical juncture to decide whether DeSci will rise again in glory or sink into oblivion.

Oversubscribed Refund 90%, New Compound EGS with "$Pain-Style" Presale Sparks Heated Discussion

At 3:19 am on February 9, Pump.Science's official Twitter commented on its upcoming compound project $EGS @EGCGxSFN, stating that "earning trust is the most appreciable thing." A look at Twitter reveals that Pump.Science's new compound project $EGS surprisingly opened a 24-hour presale window on February 7. According to on-chain data, the presale wallet address for $EGS finally raised 1223 Sol at block height 319172095. What is even more noteworthy is that the project team announced in a tweet that they will refund 91.87% of the funds raised, retaining only 100 Sol for token issuance and liquidity support. This presale's "high oversubscription refund" strategy, akin to the previously hot $Pain project, but both the refund behavior and proportion are pioneering for DeSci projects. The original tweet from the EGS team announced, "24 hours, no marketing, no whales, we proved trust in science," and declared that EGS will open at a $100k market cap to gift the diamond hands of DeSci, with early presale transactions having already gained around three times the profit.

EGS stands for the compounds Epigallocatechin Gallate and Sulforaphane. EGCG is the core active ingredient in green tea, known as the "king of antioxidants," which inhibits cellular aging by activating the AMPK pathway, eliminating free radicals to reduce oxidative damage. Studies have shown that EGCG can extend the lifespan of model organisms such as nematodes and fruit flies by up to 20%, with mechanisms including inflammation inhibition, enhanced mitochondrial function, and potential telomere lengthening through epigenetic regulation. Sulforaphane, on the other hand, derived from cruciferous vegetables like broccoli, acts as a "cell guardian" by significantly enhancing cellular antioxidant capacity through activation of the Nrf2 pathway. Experimental evidence has shown that Sulforaphane can extend the lifespan of mice by about 15%, with key roles including promoting autophagy to clear senescent cells, repairing DNA damage, and inhibiting age-related chronic inflammation (such as the NF-κB pathway). Both compounds work through multi-target synergies to delay aging and are among the few natural compounds with clinical translational potential as longevity-promoting molecules.

Apparently, the new compound has taken over the IP monetization logic of Rif and Uro in the past and has reduced risk through a presale with high refunds, which is the "low threshold, high odds" story that DeSci urgently needs. However, can such a highly discussed presale gameplay, combined with DeSci's "trust science" narrative, align with Rif and Uro after the launch of the new platform? The answer is not definite. Benjels, co-founder of Pump.Science, admitted, "The issue with DeSci is that the narrative is grand, but implementation is difficult." "Users want to support science while also hoping to gain speculative returns. Balancing these two aspects is key." In today's market where pumping is considered righteous, a singular grand narrative of decentralized science has been proven unable to gain market acceptance. The road to the rise of DeSci is still long and arduous, urgently requiring more eye-catching gameplay to capture the sensitive attention within the community. Let's hope that this time, the new compounds of Pump.Science can bring new increments to the devastated track of DeSci and, as promised in the tweet, provide wealth and spiritual solace to those DeSci diamond hands who are still holding strong.

Attachment: Pump.Science New Compound Overview

- Punicalagin & Berberine: Pomegranate polyphenols, with strong antioxidant and anti-inflammatory properties; Berberine: an AMPK activator that can regulate blood sugar and improve metabolic health. Together, pomegranate polyphenols support cardiovascular health and the anti-inflammatory pathway, complementing the metabolic effects of berberine.

- Resveratrol & Berberine: Resveratrol, a polyphenol, can activate sirtuins, improve mitochondrial efficiency, and mimic the effects of calorie restriction; Berberine: an AMPK activator that can regulate blood sugar and improve metabolic health. Together, resveratrol and berberine can both activate AMPK and sirtuins, potentially leading to longevity, metabolic control, and enhanced cellular repair capabilities.

- Ginsenoside Rh2: Ginsenoside Rh2, a bioactive compound in ginseng, with anticancer, neuroprotective, and anti-inflammatory effects.

- Aspalathin & Caffeine: Aspalathin, a bioactive flavonoid compound in rooibos tea, with antioxidant and blood sugar-lowering effects; Caffeine, a stimulant that can enhance brainpower and physical endurance. Together, aspalathin can counteract the potential negative effects of caffeine on blood sugar and stress hormones, providing a more balanced stimulant response.

- Gossypol & Catechin Hydrate: Gossypol, a polyphenol with potential anticancer and metabolic effects; Catechin hydrate, a catechin similar to EGCG, with strong antioxidant properties. Together, these two compounds can jointly regulate cellular stress responses, enhancing metabolic efficiency.

-Biotin & Berberine: Biotin, a substance essential for fatty acid metabolism, glucose regulation, and skin health; Berberine, a metabolic regulator that can increase insulin sensitivity. Together, Biotin can complement Berberine's action by improving lipid metabolism and enhancing mitochondrial function.

-Urolithin A & EGCG: Urolithin A, a metabolite extracted from pomegranate that promotes mitophagy (recycling of damaged mitochondria); EGCG, Epigallocatechin Gallate, a powerful antioxidant and anti-inflammatory compound found in green tea. Together, EGCG and Urolithin A support mitochondrial function and longevity pathways, potentially enhancing cellular energy efficiency.

-Berberine & Quercetin: Berberine, a metabolic regulator that improves insulin sensitivity, lowers blood sugar, and supports cardiovascular health; Quercetin, a flavonoid with anti-inflammatory, antioxidant, and antiviral properties that enhances nutrient absorption. Together, Quercetin can improve Berberine's bioavailability and complement its metabolic effects, thereby improving glucose regulation and mitochondrial function.

-Hesperidin & DHM (Dihydromyricetin): Hesperidin, a flavonoid compound found in citrus fruits that improves blood circulation, reduces oxidative stress, and supports vascular health; DHM, used for liver protection, alcohol metabolism support, and neuroprotection. Both compounds regulate liver enzymes and inflammatory pathways, enhancing detoxification capacity and metabolic resilience.

-EGCG: Epigallocatechin Gallate, a powerful antioxidant and anti-inflammatory compound found in green tea.

-Caffeine: a stimulant that enhances energy, cognitive function, and endurance. Liver detoxification, reducing premature death.

-Artemisinin: Artemisinin, extracted from sweet wormwood, known for its anti-malarial, anticancer, and anti-inflammatory properties.

Recently, with Binance Research once again affirming the DeSci track, BIO, Rif, and Uro have all surged by 20%. It seems that the DeSci craze is picking up steam again. At the same time, these compounds are also set to launch on the Pump.Science new platform. The wide range of token launches makes it necessary for everyone to continue to pay attention to high-quality tokens, select projects that are serious and have a solid foundation, and DYOR!

Original Article Link